This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2005 Mar;42(3):e20.

doi: 10.1136/jmg.2004.027243.

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations

B Leegte¹, A H van der Hout, A M Deffenbaugh, M K Bakker, I M Mulder, A ten Berge, E P Leenders, J Wesseling, J de Hullu, N Hoogerbrugge, M J L Ligtenberg, A Ardern-Jones, E Bancroft, A Salmon, J Barwell, R Eeles, J C Oosterwijk

Affiliations

PMID: 15744030
PMCID: PMC1736012
DOI: 10.1136/jmg.2004.027243

Review

Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations

B Leegte et al. J Med Genet. 2005 Mar.

. 2005 Mar;42(3):e20.

doi: 10.1136/jmg.2004.027243.

Authors

B Leegte¹, A H van der Hout, A M Deffenbaugh, M K Bakker, I M Mulder, A ten Berge, E P Leenders, J Wesseling, J de Hullu, N Hoogerbrugge, M J L Ligtenberg, A Ardern-Jones, E Bancroft, A Salmon, J Barwell, R Eeles, J C Oosterwijk

Affiliation

¹ Department of Clinical Genetics, Groningen University Medical Centre, Groningen, The Netherlands.

PMID: 15744030
PMCID: PMC1736012
DOI: 10.1136/jmg.2004.027243

No abstract available

PubMed Disclaimer

Similar articles

A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes.
Musolino A, Naldi N, Michiara M, Bella MA, Zanelli P, Bortesi B, Capelletti M, Savi M, Neri TM, Ardizzoni A. Musolino A, et al. Breast Cancer Res Treat. 2005 May;91(2):203-5. doi: 10.1007/s10549-004-7704-4. Breast Cancer Res Treat. 2005. PMID: 15868448
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G, Capalbo C, Ristori E, Ricevuto E, Sidoni T, Buffone A, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A. Giannini G, et al. Breast Cancer Res Treat. 2006 Nov;100(1):83-91. doi: 10.1007/s10549-006-9225-9. Epub 2006 May 9. Breast Cancer Res Treat. 2006. PMID: 16847550
Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2.
Bell DW, Erban J, Sgroi DC, Haber DA. Bell DW, et al. Cancer Res. 2002 May 15;62(10):2741-3. Cancer Res. 2002. PMID: 12019146
Genomic rearrangements in the BRCA1 and BRCA2 genes.
Mazoyer S. Mazoyer S. Hum Mutat. 2005 May;25(5):415-22. doi: 10.1002/humu.20169. Hum Mutat. 2005. PMID: 15832305 Review.
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
Fackenthal JD, Olopade OI. Fackenthal JD, et al. Nat Rev Cancer. 2007 Dec;7(12):937-48. doi: 10.1038/nrc2054. Nat Rev Cancer. 2007. PMID: 18034184 Review.

See all similar articles

Cited by

Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population.
Lavie O, Narod S, Lejbkowicz F, Dishon S, Goldberg Y, Gemer O, Rennert G. Lavie O, et al. Ann Oncol. 2011 Apr;22(4):964-966. doi: 10.1093/annonc/mdq460. Epub 2010 Oct 5. Ann Oncol. 2011. PMID: 20924075 Free PMC article.
Double heterozygosity for BRCA1 and BRCA2 in breast cancer: considerations in surveillance and cancer risk management.
Wakaki N, Shimoi T, Nakamoto S, Kikawa Y, Ito A, Iwamoto T. Wakaki N, et al. BMJ Case Rep. 2025 Apr 22;18(4):e263687. doi: 10.1136/bcr-2024-263687. BMJ Case Rep. 2025. PMID: 40262912 Free PMC article.
Use of association studies to define genetic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Hughes DJ. Hughes DJ. Fam Cancer. 2008;7(3):233-44. doi: 10.1007/s10689-008-9181-0. Epub 2008 Feb 19. Fam Cancer. 2008. PMID: 18283561 Review.
Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study.
Fewings E, Larionov A, Redman J, Goldgraben MA, Scarth J, Richardson S, Brewer C, Davidson R, Ellis I, Evans DG, Halliday D, Izatt L, Marks P, McConnell V, Verbist L, Mayes R, Clark GR, Hadfield J, Chin SF, Teixeira MR, Giger OT, Hardwick R, di Pietro M, O'Donovan M, Pharoah P, Caldas C, Fitzgerald RC, Tischkowitz M. Fewings E, et al. Lancet Gastroenterol Hepatol. 2018 Jul;3(7):489-498. doi: 10.1016/S2468-1253(18)30079-7. Epub 2018 Apr 27. Lancet Gastroenterol Hepatol. 2018. PMID: 29706558 Free PMC article.
Double Heterozygosity for BRCA1 Pathogenic Variant and BRCA2 Polymorphic Stop Codon K3326X: A Case Report in a Southern Italian Family.
Palmirotta R, Lovero D, Stucci LS, Silvestris E, Quaresmini D, Cardascia A, Silvestris F. Palmirotta R, et al. Int J Mol Sci. 2018 Jan 18;19(1):285. doi: 10.3390/ijms19010285. Int J Mol Sci. 2018. PMID: 29346284 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal